Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Calliditas Receives Conditional Marketing Authorization from UK MHRA for Kinpeygo in IgA nephropathy

Kinpeygo is the first and only approved treatment for IgAN, a rare, progressive autoimmune disease of the kidney with a high unmet need, with more than 50% of patients potentially progressing to end-stage renal
byBenzinga Newsdesk
February 2, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Kinpeygo is the first and only approved treatment for IgAN, a rare, progressive autoimmune disease of the kidney with a high unmet need, with more than 50% of patients potentially progressing to end-stage renal disease (ESRD)

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AMC Pops, Bitcoin Drops: Why We’re Seeing Another Meme Stock-Crypto Reversion And What Comes Next

By David Pinsen
Today, 6:40 AM
An observation we've made in previous posts (e.g., AMC: Return Of The Meme Stock) was that the resurgence in meme stocks last spring came as Bitcoin sagged. That made sense, as the parabolic rally in Bitcoin and other cryptocurrencies earlier in the year had siphoned some of the speculative fervor out of meme stocks.

AMC

Read More

Not-So-Transitory Inflation: In Recent Months, We’ve Posted Winning Inflation Trades. Here Are Two More Inflation Trade Ideas.

By David Pinsen
Today, 6:40 AM
A typical couple enjoying their (presumably) debt-financed breakfast in bed (image via Affirm). Economy-Wide Inflation As Washington Post economics correspondent Heather Long pointed out on Twitter recently, inflation is now hitting Americans everywhere from rental cars to rent. 

AFRM